About Lavina Pharmaceuticals Private Limited
Data last updated:
Lavina Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 December 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2004PTC149804. Its GSTIN is 27AABCL0461A1Z5 (Maharashtra).
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹25 Lakh. It is led by directors Jagdish Singh Deb Singh Shawant and Mala Jagdish Shawant.
Its last annual general meeting (AGM) was held on 20 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Thane, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹27.56 Cr, a decline of 12% compared to the previous year. For the same year it recorded a net profit of ₹67.2 Lakh (net margin 2.4%) and EBITDA of ₹1.79 Cr (EBITDA margin 6.5%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 4% over five years.
The company is associated with 1 brand: Lavina Pharma. As per MCA filings, the company has open charges of ₹1.15 Cr and satisfied charges of ₹4.5 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website lavinapharma.com.
Company details
Contact details
Lavina Pharmaceuticals Private Limited's registered office is in Thane, Maharashtra. Its website is lavinapharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressUnit No. 401 402 4th Floor Satra Plaza Plot No. 19 & 20, Sector – 19D Palm Beach Road Navi Mumbai City Vashi, Thane, Maharashtra, India – 400705
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Lavina Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Lavina Pharmaceuticals operates one associated brand: Lavina Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing and exporting of preparations in India. | lavinapharma.com |
Business activity
The main business activity of Lavina Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Lavina Pharmaceuticals Private Limited, buy the company report.
Financials of Lavina Pharmaceuticals Private Limited
FY 2025 filings availableLavina Pharmaceuticals Private Limited reported revenue of ₹27.56 Cr (down 12% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 12% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 4%. EBITDA fell 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.79 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹67.2 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.5% | ||||
| Net Profit Margin | 2.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Lavina Pharmaceuticals Private Limited, buy the company report.
Board of directors of Lavina Pharmaceuticals Private Limited
Lavina Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jagdish Singh Deb Singh Shawant Also directs: Lata-Nkb International Private Limited | Director | 03 Dec 2004 | 21 Years 10 Months | Current |
| Mala Jagdish Shawant Also directs: Lata-Nkb International Private Limited | Director | 03 Dec 2004 | 21 Years 10 Months | Current |
Auditor
Lavina Pharmaceuticals Private Limited is audited by E.A PATIL & ASSOCIATES LLP for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| E.A PATIL & ASSOCIATES LLP | FY 2024 | 117371W/W100092 |
Shareholding
The shareholding of Lavina Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Lavina Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Oct 2024 | 100998716 | Hdfc Bank Limited | ₹40 Lakh | Open | |
| 26 May 2023 | 100732389 | Karnataka Bank Ltd. | ₹75 Lakh | Open | |
| 16 Apr 2024 | 100903485 | Hdfc Bank Limited | ₹4.5 Cr | Satisfied |
To see the full charge records of Lavina Pharmaceuticals Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Lavina Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Lavina Pharmaceuticals Private Limited has 5 MSME Form 1 returns on record between 2018 and 2022, listing 13 overdue payments to 7 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 7)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Bharat Parenterals Limited | |||
| Medibios Laboratories Limited | |||
| Bajaj Healthcare Ltd-Part-A | |||
| E A Patil & Associates LLP | |||
| an individual supplier |
To see the full MSME payment records of Lavina Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Lavina Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCL0461A1Z5 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Lavina Pharmaceuticals Private Limited, buy the company report.
Recent activity
Lavina Pharmaceuticals Private Limited has 2 board changes on record since 2004: 2 appointments. The latest: Jagdish Singh Deb Singh Shawant was appointed as Director on 03 Dec 2004.
Frequently asked questions
Lavina Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 December 2004 (22+ years old) and is registered under CIN U24230MH2004PTC149804.
Lavina Pharmaceuticals has 2 current directors:
- Jagdish Singh Deb Singh Shawant - Director
- Mala Jagdish Shawant - Director
The latest financial statements of Lavina Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 20 August 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Lavina Pharmaceuticals is 27AABCL0461A1Z5, registered in Maharashtra.
The CIN (Corporate Identification Number) of Lavina Pharmaceuticals is U24230MH2004PTC149804. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lavina Pharmaceuticals was incorporated on 03 December 2004, making it 22+ years old. It is registered with the Registrar of Companies, Mumbai.
Jagdish Singh Deb Singh Shawant was appointed as Director on 03 Dec 2004. Mala Jagdish Shawant was appointed as Director on 03 Dec 2004.
Lavina Pharmaceuticals has 5 MSME Form 1 returns on record between 2018 and 2022, listing 13 overdue payments to 7 micro and small suppliers. The latest return was filed on 01 Nov 2022.
Lavina Pharmaceuticals can be reached through the website lavinapharma.com. Its registered office is in Thane, Maharashtra, India.
The registered office of Lavina Pharmaceuticals is at Unit No. 401 402 4th Floor Satra Plaza Plot No. 19 & 20, Sector – 19D Palm Beach Road Navi Mumbai City Vashi, Thane, Maharashtra, India – 400705.
Lavina Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
